Brought to you by 
Shire proposes €328mm acquisition of Jerini AG
05 Sep 2008
Executive Summary
Shire is proposing to takeover public biotech Jerini AG for €328mm ($517mm) in cash, paying €6.25 per share (an 88% premium). The day following the deal announcement, Jerini's shares jumped from €3.65 to €6.16.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Shire proposes €328mm acquisition of Jerini AG
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice